Your Complete Wegovy Transition Guide From Mounjaro
Can I Switch To Wegovy From Mounjaro: Understanding Your Starter Options
When considering whether you can switch to Wegovy from Mounjaro, the starter dose approach becomes particularly important. Unlike continuing patients, those transitioning from Mounjaro must begin Wegovy at the 0.25mg starter dose regardless of their previous Mounjaro dose level. This prescription-only medicine requires a complete restart of the dose escalation schedule to ensure safety and optimal tolerability. The 16-week escalation protocol cannot be bypassed, even if you've been on higher Mounjaro doses. Your prescriber will typically recommend stopping Mounjaro completely before beginning Wegovy, with timing depending on your individual circumstances and when you last administered your Mounjaro injection.
The transition from tirzepatide (Mounjaro) to semaglutide (Wegovy) represents a shift from dual GIP and GLP-1 receptor targeting to GLP-1 receptor focus alone. This mechanism difference means your body's response may vary compared to your Mounjaro experience. Some patients find the transition smooth, whilst others notice different appetite effects or side effect profiles. Starting with the 0.25mg dose allows your system to adapt to semaglutide's specific mechanism. EverydayMeds provides comprehensive transition support through our GPhC-registered pharmacy (#9012878), ensuring you receive proper clinical guidance throughout the switch.
Wegovy Starter Pricing For Mounjaro Switchers: Complete Cost Breakdown
Patients switching from Mounjaro to Wegovy can access the 0.25mg starter dose for £79.99 using discount code FIRST40 at checkout. This represents your first month's supply (weeks 1-4) as you begin the escalation journey. For those planning their complete transition, our Intro Duo bundle (0.25mg and 0.5mg pens) costs £169.99, covering your first two months. The Intro Trio bundle extends this to three months with 0.25mg, 0.5mg, and 1mg pens for £299.99. These bundles provide treatment continuity without requiring multiple orders during your initial Wegovy experience.
Returning customers benefit from the DOSE25 discount code for ongoing supplies after their initial purchase. The complete Wegovy escalation involves five dose levels: 0.25mg (£79.99), 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), and maintenance 2.4mg (£209.99). For patients requiring extended time at the starter dose, our Consistency 0.25mg bundle provides two pens for £139.99. All prices include our clinical assessment, prescriber review, and next-day cold-chain delivery once approved. Express prescriber review is available for £10 additional if you need faster treatment continuity during your switch.
Clinical Evidence Supporting Your Switch To Wegovy From Mounjaro
The STEP trial programme demonstrates Wegovy's efficacy as a standalone GLP-1 treatment option for patients switching from other weight management medications. In the pivotal STEP 1 trial (Wilding et al., NEJM, 2021), patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks. The SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events, providing additional confidence for patients with cardiovascular risk factors.
Patients switching from Mounjaro to Wegovy may experience different response patterns due to the mechanism differences between dual GIP/GLP-1 activation and GLP-1-only targeting. Some individuals respond better to semaglutide's specific receptor binding profile, whilst others prefer tirzepatide's dual approach. Clinical evidence suggests both medications can be effective when used alongside a reduced-calorie diet and increased physical activity, with individual response varying based on multiple factors including genetics, lifestyle, and concurrent medications.
How Wegovy Works Differently From Mounjaro During Your Switch
Understanding the mechanism difference helps explain why you must restart at the 0.25mg dose when switching to Wegovy from Mounjaro. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormone to reduce appetite and promote satiety after smaller meals. Unlike Mounjaro's dual GIP and GLP-1 receptor targeting, Wegovy focuses exclusively on GLP-1 pathways in your brain's appetite control centres. This focused approach may produce different hunger patterns, food cravings, and side effect profiles compared to your Mounjaro experience. The once-weekly injection schedule remains similar, but the FlexTouch pen delivery system differs from Mounjaro's KwikPen design. Some patients find semaglutide's mechanism provides more consistent appetite suppression throughout the week, whilst others prefer tirzepatide's broader hormonal effects.
Ordering Process For Your Mounjaro To Wegovy Transition
Switching to Wegovy from Mounjaro begins with our 3-minute online clinical assessment, where you'll indicate your previous Mounjaro experience and reasons for switching. Our prescribers review your medical history, current medications, and transition timeline to ensure safe changeover timing. Standard prescriber review takes 3 working days, though express 24-hour review (£10 additional) may be appropriate for treatment continuity. Once approved, your Wegovy starter dose ships via next-day cold-chain delivery in temperature-controlled packaging. Our clinical team provides transition guidance including timing recommendations for stopping Mounjaro and starting Wegovy based on your individual circumstances.
Storage Advantages When You Switch To Wegovy From Mounjaro
One practical benefit when switching to Wegovy from Mounjaro involves storage flexibility, particularly for frequent travellers. Wegovy pens maintain potency for up to 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This storage advantage proves valuable for extended trips, work travel, or situations where refrigeration access is uncertain. Both medications require initial refrigerated storage (2-8°C) before first use, but Wegovy's extended room temperature stability offers greater lifestyle flexibility. The FlexTouch pen design includes a dose counter and safety features, though the injection technique remains similar to your Mounjaro experience. Always store unused pens in the original packaging to protect from light, and never freeze or shake either medication.
Dose Escalation Timeline When Switching To Wegovy From Mounjaro
Patients switching to Wegovy from Mounjaro must complete the full 16-week dose escalation regardless of their previous tirzepatide dose level. This safety requirement exists because semaglutide and tirzepatide have different pharmacological profiles despite both being weekly injections. Your escalation schedule progresses from 0.25mg (weeks 1-4) to 0.5mg (weeks 5-8), then 1mg (weeks 9-12), 1.7mg (weeks 13-16), and finally 2.4mg maintenance from week 17 onwards. Some prescribers recommend extending time at lower doses if you experience side effects during transition. The newly approved 7.2mg dose (available from 2026) may eventually provide options for patients requiring higher maintenance doses.
Planning your switch timeline involves coordinating Mounjaro cessation with Wegovy initiation based on your prescriber's guidance. Most patients stop Mounjaro and begin Wegovy within the same week, though individual timing may vary. Our bundle options support this escalation journey—the Intro Trio covers months 1-3, whilst the Progress Trio spans months 2-4 if you need overlapping supplies. Each dose level serves a specific purpose in building tolerance whilst maintaining efficacy, making the escalation schedule a crucial component of successful switching from Mounjaro to Wegovy.
Final Steps To Switch To Wegovy From Mounjaro With EverydayMeds
Ready to switch to Wegovy from Mounjaro? Start your transition with our 0.25mg starter dose at £79.99 using code FIRST40 for new customers, or DOSE25 for returning patients. Visit https://everydaymeds.co.uk/products/wegovy-0-25mg to begin your clinical assessment and discuss your switching timeline with our prescribers. Our GPhC-registered pharmacy (#9012878) ensures safe, legal supply with comprehensive clinical oversight throughout your transition. Consider our Intro Duo or Intro Trio bundles for extended supply security during your early Wegovy experience. Remember that weight management is a long-term commitment, and switching medications should always be guided by qualified healthcare professionals who understand your individual circumstances and treatment history.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
